Press Releases.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 06, 2019Term Loan Amended to Provide Up to Two Years of Interest Only Payments and Extension of Maturity Date to May 2022
-
May 06, 2019Up to $41.8 Million in Gross Proceeds to be Funded in Two Tranches
-
April 08, 2019Favorable Pharmacological Properties Exhibited in Preclinical Models of NASH
-
March 15, 2019
-
January 04, 2019No Adverse or Other Significant Findings to Date Across All Dose Groups Tested
-
November 19, 2018Single Dose of Lead anti-miR-10b Compound in Combination with temozolomide Resulted in over 150% Increase in Median Survival
-
November 08, 2018$47 Million Restructured Sanofi Collaboration Executed
-
November 06, 2018Sanofi Will Assume Development of RG-012 for Alport syndrome
-
October 18, 2018
-
October 04, 2018
-
September 27, 2018
-
September 26, 2018Hepatitis B virus Lead Compound Demonstrates Compelling Data in Preclinical Studies
-
August 09, 2018Corporate Restructuring and Pipeline Focus Expected to Extend Cash Runway
-
July 05, 2018Efforts Aimed at Extending Cash Runway to mid-2019
-
May 10, 2018Two pre-clinical programs advance towards clinical candidates
-
May 03, 2018Conference Call and Webcast to Follow
-
May 01, 2018Initial safety and pharmacokinetic results from single ascending dose study support advancement
-
April 17, 2018
-
March 20, 2018